FDA Laboratory Benchtop Luminometer
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA), specifically the Center for Biologics and Review (CBER), Office of Vaccine Research and Review (OVRR), Laboratory of Hepatitis Viruses (LHV), is conducting a Sources Sought market survey to identify potential sources for a Laboratory Benchtop Luminometer. This instrument is crucial for reading luminescence in cell expression and hepatitis C studies, replacing a non-operational unit. Responses are due June 1, 2026.
Scope of Work
The required luminometer must meet the following key specifications:
- Capable of reading 96-well plates.
- Include an injection system with a minimum of two injectors for variable volume luciferase reagent delivery.
- Spectral range: 340-630nm.
- Sensitivity: Less than 5 amol ATP per well and less than 2 Zeptomoles of firefly luciferase.
- Dynamic range: Greater than 6 orders of magnitude.
- Must include computer software for instrument operation, plate setup, and data analysis.
- Minimum of one-year full manufacturer's warranty.
- Installation and staff training are required.
Contract & Timeline
- Type: Sources Sought / Market Survey
- NAICS Code: 334516 (Analytical Laboratory Instrument Manufacturing)
- Small Business Size Standard: 1,000 employees
- Response Due: June 1, 2026, at 2:00 PM Central Time
- Published: May 26, 2026
Submission & Evaluation
Interested contractors must submit capability statements via email to timothy.walbert@fda.hhs.gov. The email subject line must reference "75F40126SSN1334302". Responses should clearly demonstrate capability, not merely affirm it. Submissions containing web links will not be opened. This is not a solicitation, and no contract will be awarded from this notice. The government will not reimburse costs for providing information.
Eligibility / Set-Aside
This opportunity falls under NAICS Code 334516. Small businesses are specifically encouraged to respond with capability statements, though other than small (large) businesses are also welcome to submit.
Additional Notes
Informational pricing for the equipment and service would be helpful for the FDA's market research. Proprietary, classified, confidential, or sensitive information should not be included in responses.